These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 283720)

  • 21. Drug interactions between opioids and antiretroviral medications: interaction between methadone, LAAM, and nelfinavir.
    McCance-Katz EF; Rainey PM; Smith P; Morse G; Friedland G; Gourevitch M; Jatlow P
    Am J Addict; 2004; 13(2):163-80. PubMed ID: 15204667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV risk behaviors during pharmacologic treatment for opioid dependence: a comparison of levomethadyl acetate [corrected] buprenorphine, and methadone.
    Lott DC; Strain EC; Brooner RK; Bigelow GE; Johnson RE
    J Subst Abuse Treat; 2006 Sep; 31(2):187-94. PubMed ID: 16919747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Basic concepts and use of cyclazocine in the treatment of narcotic addiction.
    Freedman AM; Fink M
    Br J Addict Alcohol Other Drugs; 1968 Sep; 63(1):59-69. PubMed ID: 5245946
    [No Abstract]   [Full Text] [Related]  

  • 24. 28. Methadone maintenance and its implication for theories of narcotic addiction.
    Dole VP; Nyswander ME
    Res Publ Assoc Res Nerv Ment Dis; 1968; 46():359-66. PubMed ID: 5723803
    [No Abstract]   [Full Text] [Related]  

  • 25. Chronic l-alpha acetylmethadol in rhesus monkeys: discriminative stimulus and other behavioral measures of dependence and withdrawal.
    Brandt MR; France CP
    J Pharmacol Exp Ther; 1998 Dec; 287(3):1029-37. PubMed ID: 9864289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacologic factors in relapse and the possible use of the narcotic antagonists in treatment.
    Martin WR
    IMJ Ill Med J; 1966 Oct; 130(4):489-94. PubMed ID: 4380652
    [No Abstract]   [Full Text] [Related]  

  • 27. NIDA's Medication Development Program--1989.
    Schuster CR; Snyder M
    NIDA Res Monogr; 1989; 95():64-73. PubMed ID: 2641056
    [No Abstract]   [Full Text] [Related]  

  • 28. Narcotic antagonists: naltrexone progress report: foreword.
    Jaffe J
    NIDA Res Monogr; 1976 Sep; (9):v-vii. PubMed ID: 1088898
    [No Abstract]   [Full Text] [Related]  

  • 29. LAAM--a long-acting methadone for treatment of heroin addiction.
    Med Lett Drugs Ther; 1994 Jun; 36(924):52. PubMed ID: 8196570
    [No Abstract]   [Full Text] [Related]  

  • 30. A point of view concerning treatment approaches with narcotic antagonists.
    Resnick RB; Schuyten-Resnick E
    NIDA Res Monogr; 1976 Sep; (9):84-7. PubMed ID: 1004532
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of opioid dependence pharmacotherapies on zidovudine disposition.
    McCance-Katz EF; Rainey PM; Friedland G; Kosten TR; Jatlow P
    Am J Addict; 2001; 10(4):296-307. PubMed ID: 11783744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Addiction and the community. (Narcotic substitution therapy).
    Taylor WJ; Chambers CD; Bowling CE
    Int J Clin Pharmacol; 1972 Apr; 6(1):28-39. PubMed ID: 4625924
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical status of methadyl acetate (LAAM).
    Blaine JD; Renault PR; Thomas DB; Whysner JA
    Ann N Y Acad Sci; 1981; 362():101-15. PubMed ID: 7020527
    [No Abstract]   [Full Text] [Related]  

  • 34. Narcotic antagonists: another approach to addiction therapy.
    Fink M; Freedman AM; Zaks AM; Resnick RB
    Am J Nurs; 1971 Jul; 71(7):1359-63. PubMed ID: 5207098
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical studies of cyclazocine in the treatment of narcotic addiction.
    Freedman AM; Fink M; Sharoff R; Zaks A
    Am J Psychiatry; 1968 May; 124(11):1499-504. PubMed ID: 4869436
    [No Abstract]   [Full Text] [Related]  

  • 36. Methadone vs. L-alpha-acetylmethadol (LAAM) in the treatment of opiate addiction. A meta-analysis of the randomized, controlled trials.
    Glanz M; Klawansky S; McAullife W; Chalmers T
    Am J Addict; 1997; 6(4):339-49. PubMed ID: 9398932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safe approaches to treating drug addiction.
    Keaney F; Farrell M
    Practitioner; 2000 May; 244(1610):410, 414-6, 418-20 passim. PubMed ID: 10962832
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacotherapy for the opioid addict: agonists or antagonists?
    Ketchum JS; Jarvik ME
    Ration Drug Ther; 1979 Jan; 13(1):1-5. PubMed ID: 451229
    [No Abstract]   [Full Text] [Related]  

  • 39. Human pharmacology of narcotic antagonists.
    Jasinski DR
    Br J Clin Pharmacol; 1979; 7 Suppl 3(Suppl 3):287S-290S. PubMed ID: 465291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [New drugs for substitution treatment of opioid dependence. Buprenorphine and 1-alpha-acetylmethadol (LAAM) ].
    Petersen H; Skauge L; Svejsø J; Ege PP
    Ugeskr Laeger; 2000 Nov; 162(48):6553-6. PubMed ID: 11187226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.